Related Experiment Video
Updated: Apr 30, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
Vasopressin administration in refractory cardiac arrest
K H Lindner1, A W Prengel, A Brinkmann
1University of Ulm, Germany.
Vasopressin administration promptly restored spontaneous circulation in cardiac arrest patients refractory to epinephrine. While promising, further studies are needed to confirm its efficacy compared to standard treatments.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Outcomes of cardiopulmonary resuscitation (CPR) remain poor.
- Animal studies suggest vasopressin improves organ blood flow during CPR more effectively than epinephrine.
- Epinephrine is the current standard of care for cardiac arrest.
Observation:
- Eight adult patients with in-hospital cardiac arrest were studied.
- Vasopressin (40 U IV) was administered after epinephrine and defibrillation failed.
- Return of spontaneous circulation and hospital discharge were assessed.
Findings:
- All patients receiving vasopressin experienced prompt return of spontaneous circulation.
- Three patients were discharged with intact neurological function.
- Survival ranged from 30 minutes to 82 hours for the other five patients.
Implications:
- Vasopressin may be more potent than adrenergic vasopressors in restoring cardiovascular function during cardiac arrest with severe hypoxia and acidosis.
- Widespread use for refractory cardiac arrest is not yet justified.
- Further comparative studies of vasopressin versus epinephrine are warranted to improve cardiac arrest prognosis.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure V: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

